Share Price and Basic Stock Data
Last Updated: February 3, 2026, 2:17 am
| PEG Ratio | -269.42 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Gujarat Alkalies & Chemicals Ltd operates in the chemicals sector, primarily focusing on inorganic chemicals like caustic soda and soda ash. As of September 2023, the company’s share price stood at ₹445 with a market capitalization of ₹3,264 Cr. The company recorded sales of ₹4,516 Cr for the fiscal year ending March 2023, which represented a significant increase compared to ₹3,759 Cr in the previous fiscal year. However, revenue trends show volatility, with quarterly sales peaking at ₹1,138 Cr in March 2023 and declining to ₹913 Cr by June 2023 before partially recovering to ₹971 Cr in September 2023. This inconsistency may be attributed to fluctuations in demand and pricing pressures in the chemical market. The trailing twelve months (TTM) revenue of ₹4,293 Cr indicates a slight decline from the previous fiscal year, suggesting challenges in maintaining growth momentum in a competitive landscape.
Profitability and Efficiency Metrics
Profitability metrics for Gujarat Alkalies & Chemicals Ltd have shown a concerning trend, particularly in the latest fiscal periods. The operating profit margin (OPM) fell sharply from 21% in December 2022 to a mere 2% in September 2023, reflecting significant cost pressures and reduced pricing power. The company reported a net profit of ₹410 Cr for FY 2023, but subsequent quarters have seen net losses, including a notable loss of ₹115 Cr in December 2023. The interest coverage ratio (ICR) stood at 8.95x, indicating that the company can comfortably meet its interest obligations, although this figure has declined compared to previous years. The return on equity (ROE) and return on capital employed (ROCE) were reported at 1.13% and 0.34%, respectively, both significantly lower than typical industry benchmarks, reflecting inefficiencies in asset utilization and capital management.
Balance Sheet Strength and Financial Ratios
The balance sheet of Gujarat Alkalies & Chemicals Ltd exhibits a mixed picture of financial health. As of March 2025, the company reported total assets of ₹7,987 Cr, with total liabilities amounting to ₹8,209 Cr, resulting in a modest debt-to-equity ratio of 0.09. Reserves stood at ₹5,596 Cr, which provides a cushion for operational challenges. However, the company’s borrowing has increased to ₹561 Cr, raising concerns about its long-term financial commitments. The price-to-book value (P/BV) ratio of 0.75x suggests that the stock is trading below its book value, potentially indicating undervaluation compared to peers. Additionally, the current ratio of 1.13x indicates adequate liquidity to cover short-term obligations, while the quick ratio of 0.60x shows some vulnerability in immediate liquidity. Overall, while the balance sheet shows stability, the rising borrowings and declining profitability metrics are areas of concern.
Shareholding Pattern and Investor Confidence
Gujarat Alkalies & Chemicals Ltd’s shareholding pattern reveals a stable but cautious investor sentiment. Promoters hold a consistent 46.28% stake, suggesting strong insider confidence in the company’s long-term prospects. Foreign institutional investors (FIIs) have reduced their holdings from 2.07% in March 2023 to 1.02% by September 2025, indicating a retreat from the stock amidst profitability concerns. Domestic institutional investors (DIIs) increased their stake to 4.52%, signaling some level of confidence. The number of shareholders decreased from 85,354 in December 2022 to 70,371 in September 2025, reflecting potential concerns regarding the company’s future performance. The public’s shareholding remained at 48.16%, suggesting a balanced distribution of ownership. This mixed sentiment may impact the stock’s liquidity and overall market perception, especially given the recent financial challenges faced by the company.
Outlook, Risks, and Final Insight
Looking ahead, Gujarat Alkalies & Chemicals Ltd faces both opportunities and challenges. The company’s ability to stabilize its profitability and manage cost pressures will be crucial. Key risks include fluctuating raw material costs, which could further squeeze margins, and potential declines in demand for its products due to economic headwinds. Conversely, the company’s strong reserve position provides a buffer against short-term volatility and may facilitate strategic investments for growth. Additionally, if Gujarat Alkalies can capitalize on emerging market trends in the chemical sector, such as sustainability initiatives, it could enhance its market position. Overall, while the company has foundational strengths, the path forward requires careful navigation of operational challenges to restore investor confidence and ensure long-term viability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Caprolactam Chemicals Ltd | 32.1 Cr. | 69.7 | 81.0/37.5 | 3,207 | 11.6 | 0.00 % | 0.48 % | 13.7 % | 10.0 |
| Standard Industries Ltd | 91.5 Cr. | 14.2 | 26.9/13.0 | 20.4 | 0.00 % | 7.81 % | 10.5 % | 5.00 | |
| Gujarat Alkalies & Chemicals Ltd | 3,264 Cr. | 445 | 700/418 | 21,763 | 759 | 3.55 % | 0.34 % | 1.13 % | 10.0 |
| GHCL Ltd | 4,734 Cr. | 515 | 715/511 | 9.34 | 396 | 2.33 % | 24.2 % | 18.6 % | 10.0 |
| Tata Chemicals Ltd | 18,507 Cr. | 727 | 1,027/692 | 68.0 | 877 | 1.51 % | 3.96 % | 1.20 % | 10.0 |
| Industry Average | 6,772.50 Cr | 362.82 | 5,021.31 | 392.00 | 1.28% | 7.11% | 8.14% | 9.17 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,127 | 1,123 | 1,138 | 913 | 971 | 921 | 1,002 | 977 | 991 | 1,029 | 1,075 | 1,105 | 1,083 |
| Expenses | 969 | 885 | 936 | 882 | 955 | 941 | 998 | 923 | 945 | 951 | 974 | 1,010 | 1,009 |
| Operating Profit | 159 | 238 | 202 | 31 | 16 | -20 | 4 | 54 | 46 | 78 | 101 | 95 | 74 |
| OPM % | 14% | 21% | 18% | 3% | 2% | -2% | 0% | 6% | 5% | 8% | 9% | 9% | 7% |
| Other Income | 22 | 6 | 8 | 12 | 71 | 5 | 3 | 3 | 49 | 15 | 24 | 8 | 59 |
| Interest | 3 | 8 | 8 | 10 | 11 | 11 | 12 | 11 | 11 | 10 | 18 | 14 | 16 |
| Depreciation | 60 | 79 | 88 | 89 | 95 | 96 | 97 | 97 | 100 | 98 | 97 | 102 | 104 |
| Profit before tax | 118 | 157 | 115 | -57 | -18 | -123 | -102 | -50 | -16 | -15 | 10 | -12 | 14 |
| Tax % | 49% | 44% | 38% | 0% | -0% | -6% | -55% | -11% | 15% | -27% | 13% | 15% | -21% |
| Net Profit | 61 | 87 | 71 | -57 | -18 | -115 | -46 | -45 | -18 | -11 | 9 | -14 | 16 |
| EPS in Rs | 8.24 | 11.87 | 9.67 | -7.78 | -2.50 | -15.68 | -6.29 | -6.06 | -2.48 | -1.53 | 1.20 | -1.88 | 2.23 |
Last Updated: January 1, 2026, 1:16 pm
Below is a detailed analysis of the quarterly data for Gujarat Alkalies & Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,083.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,105.00 Cr. (Jun 2025) to 1,083.00 Cr., marking a decrease of 22.00 Cr..
- For Expenses, as of Sep 2025, the value is 1,009.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,010.00 Cr. (Jun 2025) to 1,009.00 Cr., marking a decrease of 1.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 74.00 Cr.. The value appears to be declining and may need further review. It has decreased from 95.00 Cr. (Jun 2025) to 74.00 Cr., marking a decrease of 21.00 Cr..
- For OPM %, as of Sep 2025, the value is 7.00%. The value appears to be declining and may need further review. It has decreased from 9.00% (Jun 2025) to 7.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Jun 2025) to 59.00 Cr., marking an increase of 51.00 Cr..
- For Interest, as of Sep 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Jun 2025) to 16.00 Cr., marking an increase of 2.00 Cr..
- For Depreciation, as of Sep 2025, the value is 104.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 102.00 Cr. (Jun 2025) to 104.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from -12.00 Cr. (Jun 2025) to 14.00 Cr., marking an increase of 26.00 Cr..
- For Tax %, as of Sep 2025, the value is -21.00%. The value appears to be improving (decreasing) as expected. It has decreased from 15.00% (Jun 2025) to -21.00%, marking a decrease of 36.00%.
- For Net Profit, as of Sep 2025, the value is 16.00 Cr.. The value appears strong and on an upward trend. It has increased from -14.00 Cr. (Jun 2025) to 16.00 Cr., marking an increase of 30.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.23. The value appears strong and on an upward trend. It has increased from -1.88 (Jun 2025) to 2.23, marking an increase of 4.11.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:17 am
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,995 | 2,070 | 2,455 | 3,161 | 2,725 | 2,429 | 3,759 | 4,516 | 3,807 | 4,073 | 4,293 |
| Expenses | 1,660 | 1,622 | 1,669 | 2,046 | 2,148 | 2,072 | 2,774 | 3,568 | 3,775 | 3,793 | 3,945 |
| Operating Profit | 335 | 448 | 786 | 1,115 | 577 | 357 | 984 | 949 | 32 | 279 | 348 |
| OPM % | 17% | 22% | 32% | 35% | 21% | 15% | 26% | 21% | 1% | 7% | 8% |
| Other Income | 45 | 56 | 106 | 62 | 90 | 67 | 46 | 42 | 90 | 92 | 107 |
| Interest | 10 | 13 | 15 | 21 | 14 | 15 | 6 | 19 | 45 | 51 | 58 |
| Depreciation | 107 | 111 | 127 | 140 | 162 | 174 | 198 | 276 | 377 | 392 | 401 |
| Profit before tax | 262 | 381 | 749 | 1,016 | 491 | 235 | 826 | 695 | -300 | -71 | -4 |
| Tax % | 16% | 19% | 29% | 32% | 32% | 29% | 32% | 41% | -21% | -9% | |
| Net Profit | 220 | 307 | 534 | 690 | 332 | 166 | 560 | 410 | -237 | -65 | 0 |
| EPS in Rs | 29.90 | 41.85 | 72.78 | 93.98 | 45.22 | 22.57 | 76.22 | 55.78 | -32.25 | -8.87 | 0.02 |
| Dividend Payout % | 15% | 12% | 9% | 9% | 18% | 35% | 13% | 42% | -43% | -178% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 39.55% | 73.94% | 29.21% | -51.88% | -50.00% | 237.35% | -26.79% | -157.80% | 72.57% |
| Change in YoY Net Profit Growth (%) | 0.00% | 34.40% | -44.73% | -81.10% | 1.88% | 287.35% | -264.14% | -131.02% | 230.38% |
Gujarat Alkalies & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | 3% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 85% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 11% |
| 3 Years: | -15% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 3% |
| 3 Years: | 1% |
| Last Year: | -1% |
Last Updated: September 5, 2025, 5:30 am
Balance Sheet
Last Updated: December 4, 2025, 1:19 am
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 | 73 |
| Reserves | 2,854 | 3,282 | 3,748 | 4,222 | 4,522 | 5,301 | 5,826 | 6,066 | 6,002 | 5,596 | 5,497 |
| Borrowings | 295 | 353 | 291 | 247 | 205 | 498 | 594 | 597 | 544 | 561 | 637 |
| Other Liabilities | 671 | 726 | 859 | 988 | 1,090 | 1,282 | 1,484 | 1,599 | 1,404 | 1,756 | 2,002 |
| Total Liabilities | 3,894 | 4,435 | 4,970 | 5,531 | 5,891 | 7,154 | 7,977 | 8,335 | 8,023 | 7,987 | 8,209 |
| Fixed Assets | 1,821 | 2,073 | 2,104 | 2,300 | 2,610 | 2,587 | 2,702 | 4,250 | 4,617 | 4,584 | 4,522 |
| CWIP | 83 | 151 | 252 | 307 | 445 | 1,109 | 1,787 | 544 | 95 | 79 | 37 |
| Investments | 854 | 1,016 | 1,145 | 1,065 | 1,242 | 2,092 | 2,110 | 1,831 | 2,093 | 1,976 | 2,044 |
| Other Assets | 1,136 | 1,196 | 1,469 | 1,858 | 1,594 | 1,366 | 1,379 | 1,710 | 1,218 | 1,348 | 1,607 |
| Total Assets | 3,894 | 4,435 | 4,970 | 5,531 | 5,891 | 7,154 | 7,977 | 8,335 | 8,023 | 7,987 | 8,209 |
Below is a detailed analysis of the balance sheet data for Gujarat Alkalies & Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 73.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 73.00 Cr..
- For Reserves, as of Sep 2025, the value is 5,497.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,596.00 Cr. (Mar 2025) to 5,497.00 Cr., marking a decrease of 99.00 Cr..
- For Borrowings, as of Sep 2025, the value is 637.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 561.00 Cr. (Mar 2025) to 637.00 Cr., marking an increase of 76.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 2,002.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,756.00 Cr. (Mar 2025) to 2,002.00 Cr., marking an increase of 246.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 8,209.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,987.00 Cr. (Mar 2025) to 8,209.00 Cr., marking an increase of 222.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 4,522.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,584.00 Cr. (Mar 2025) to 4,522.00 Cr., marking a decrease of 62.00 Cr..
- For CWIP, as of Sep 2025, the value is 37.00 Cr.. The value appears to be declining and may need further review. It has decreased from 79.00 Cr. (Mar 2025) to 37.00 Cr., marking a decrease of 42.00 Cr..
- For Investments, as of Sep 2025, the value is 2,044.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,976.00 Cr. (Mar 2025) to 2,044.00 Cr., marking an increase of 68.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,607.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,348.00 Cr. (Mar 2025) to 1,607.00 Cr., marking an increase of 259.00 Cr..
- For Total Assets, as of Sep 2025, the value is 8,209.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,987.00 Cr. (Mar 2025) to 8,209.00 Cr., marking an increase of 222.00 Cr..
Notably, the Reserves (5,497.00 Cr.) exceed the Borrowings (637.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 40.00 | 95.00 | 495.00 | -246.00 | 372.00 | -141.00 | 390.00 | 352.00 | -512.00 | -282.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 60 | 58 | 60 | 56 | 50 | 43 | 29 | 23 | 17 | 24 |
| Inventory Days | 99 | 94 | 147 | 99 | 92 | 88 | 101 | 111 | 93 | 110 |
| Days Payable | 99 | 125 | 154 | 134 | 126 | 111 | 101 | 119 | 86 | 115 |
| Cash Conversion Cycle | 60 | 27 | 53 | 22 | 17 | 21 | 29 | 15 | 25 | 19 |
| Working Capital Days | 89 | 81 | 98 | 96 | 107 | 10 | 4 | 5 | -1 | -3 |
| ROCE % | 11% | 18% | 24% | 11% | 5% | 13% | 11% | -4% | -0% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Smallcap Fund | 1,746,809 | 1.05 | 88.08 | 1,745,000 | 2025-12-15 00:33:14 | 0.1% |
| ICICI Prudential PSU Equity Fund | 312,307 | 0.83 | 15.75 | N/A | N/A | N/A |
| ICICI Prudential Childrens Fund | 100,338 | 0.36 | 5.06 | N/A | N/A | N/A |
| ICICI Prudential Manufacturing Fund | 94,975 | 0.07 | 4.79 | N/A | N/A | N/A |
| ICICI Prudential Regular Savings Fund | 70,257 | 0.11 | 3.54 | 75,047 | 2025-12-07 09:28:07 | -6.38% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -8.87 | -32.25 | 55.78 | 76.22 | 22.57 |
| Diluted EPS (Rs.) | -8.87 | -32.25 | 55.78 | 76.22 | 22.57 |
| Cash EPS (Rs.) | 55.57 | 33.38 | 115.99 | 103.46 | 46.46 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 772.02 | 827.30 | 835.97 | 803.30 | 731.86 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 772.02 | 827.30 | 835.97 | 803.30 | 731.86 |
| Revenue From Operations / Share (Rs.) | 554.60 | 518.34 | 615.01 | 511.82 | 330.82 |
| PBDIT / Share (Rs.) | 61.62 | 30.79 | 157.51 | 140.60 | 57.96 |
| PBIT / Share (Rs.) | 8.21 | -20.60 | 119.92 | 113.67 | 34.21 |
| PBT / Share (Rs.) | 1.32 | -26.67 | 117.27 | 112.83 | 32.11 |
| Net Profit / Share (Rs.) | 2.15 | -18.01 | 78.39 | 76.52 | 22.72 |
| NP After MI And SOA / Share (Rs.) | -8.87 | -32.25 | 55.78 | 76.22 | 22.57 |
| PBDIT Margin (%) | 11.11 | 5.93 | 25.61 | 27.47 | 17.51 |
| PBIT Margin (%) | 1.47 | -3.97 | 19.49 | 22.20 | 10.34 |
| PBT Margin (%) | 0.23 | -5.14 | 19.06 | 22.04 | 9.70 |
| Net Profit Margin (%) | 0.38 | -3.47 | 12.74 | 14.95 | 6.86 |
| NP After MI And SOA Margin (%) | -1.59 | -6.22 | 9.06 | 14.89 | 6.82 |
| Return on Networth / Equity (%) | -1.14 | -3.89 | 6.67 | 9.48 | 3.08 |
| Return on Capital Employeed (%) | 0.85 | -2.07 | 11.75 | 11.52 | 3.84 |
| Return On Assets (%) | -0.81 | -2.95 | 4.91 | 7.01 | 2.31 |
| Long Term Debt / Equity (X) | 0.05 | 0.05 | 0.07 | 0.09 | 0.08 |
| Total Debt / Equity (X) | 0.09 | 0.08 | 0.09 | 0.10 | 0.08 |
| Asset Turnover Ratio (%) | 0.50 | 0.46 | 0.55 | 0.49 | 0.37 |
| Current Ratio (X) | 1.13 | 1.23 | 1.68 | 1.49 | 1.78 |
| Quick Ratio (X) | 0.60 | 0.67 | 1.13 | 1.01 | 1.41 |
| Inventory Turnover Ratio (X) | 9.12 | 6.75 | 6.45 | 6.97 | 6.16 |
| Dividend Payout Ratio (NP) (%) | -156.19 | -73.02 | 17.92 | 10.49 | 35.44 |
| Dividend Payout Ratio (CP) (%) | 31.08 | 123.03 | 10.70 | 7.75 | 17.27 |
| Earning Retention Ratio (%) | 256.19 | 173.02 | 82.08 | 89.51 | 64.56 |
| Cash Earning Retention Ratio (%) | 68.92 | -23.03 | 89.30 | 92.25 | 82.73 |
| Interest Coverage Ratio (X) | 8.95 | 5.07 | 59.43 | 168.00 | 27.53 |
| Interest Coverage Ratio (Post Tax) (X) | 1.31 | -1.97 | 30.58 | 92.43 | 11.79 |
| Enterprise Value (Cr.) | 4670.05 | 5324.43 | 4435.11 | 6873.06 | 2607.27 |
| EV / Net Operating Revenue (X) | 1.15 | 1.40 | 0.98 | 1.83 | 1.07 |
| EV / EBITDA (X) | 10.32 | 23.55 | 3.83 | 6.66 | 6.13 |
| MarketCap / Net Operating Revenue (X) | 1.04 | 1.30 | 0.95 | 1.75 | 1.04 |
| Retention Ratios (%) | 256.19 | 173.02 | 82.07 | 89.50 | 64.55 |
| Price / BV (X) | 0.75 | 0.81 | 0.70 | 1.12 | 0.47 |
| Price / Net Operating Revenue (X) | 1.04 | 1.30 | 0.95 | 1.75 | 1.04 |
| EarningsYield | -0.01 | -0.04 | 0.09 | 0.08 | 0.06 |
After reviewing the key financial ratios for Gujarat Alkalies & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -8.87. This value is below the healthy minimum of 5. It has increased from -32.25 (Mar 24) to -8.87, marking an increase of 23.38.
- For Diluted EPS (Rs.), as of Mar 25, the value is -8.87. This value is below the healthy minimum of 5. It has increased from -32.25 (Mar 24) to -8.87, marking an increase of 23.38.
- For Cash EPS (Rs.), as of Mar 25, the value is 55.57. This value is within the healthy range. It has increased from 33.38 (Mar 24) to 55.57, marking an increase of 22.19.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 772.02. It has decreased from 827.30 (Mar 24) to 772.02, marking a decrease of 55.28.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 772.02. It has decreased from 827.30 (Mar 24) to 772.02, marking a decrease of 55.28.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 554.60. It has increased from 518.34 (Mar 24) to 554.60, marking an increase of 36.26.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 61.62. This value is within the healthy range. It has increased from 30.79 (Mar 24) to 61.62, marking an increase of 30.83.
- For PBIT / Share (Rs.), as of Mar 25, the value is 8.21. This value is within the healthy range. It has increased from -20.60 (Mar 24) to 8.21, marking an increase of 28.81.
- For PBT / Share (Rs.), as of Mar 25, the value is 1.32. This value is within the healthy range. It has increased from -26.67 (Mar 24) to 1.32, marking an increase of 27.99.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 2.15. This value is within the healthy range. It has increased from -18.01 (Mar 24) to 2.15, marking an increase of 20.16.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -8.87. This value is below the healthy minimum of 2. It has increased from -32.25 (Mar 24) to -8.87, marking an increase of 23.38.
- For PBDIT Margin (%), as of Mar 25, the value is 11.11. This value is within the healthy range. It has increased from 5.93 (Mar 24) to 11.11, marking an increase of 5.18.
- For PBIT Margin (%), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 10. It has increased from -3.97 (Mar 24) to 1.47, marking an increase of 5.44.
- For PBT Margin (%), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 10. It has increased from -5.14 (Mar 24) to 0.23, marking an increase of 5.37.
- For Net Profit Margin (%), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 5. It has increased from -3.47 (Mar 24) to 0.38, marking an increase of 3.85.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -1.59. This value is below the healthy minimum of 8. It has increased from -6.22 (Mar 24) to -1.59, marking an increase of 4.63.
- For Return on Networth / Equity (%), as of Mar 25, the value is -1.14. This value is below the healthy minimum of 15. It has increased from -3.89 (Mar 24) to -1.14, marking an increase of 2.75.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 10. It has increased from -2.07 (Mar 24) to 0.85, marking an increase of 2.92.
- For Return On Assets (%), as of Mar 25, the value is -0.81. This value is below the healthy minimum of 5. It has increased from -2.95 (Mar 24) to -0.81, marking an increase of 2.14.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.09. This value is within the healthy range. It has increased from 0.08 (Mar 24) to 0.09, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.50. It has increased from 0.46 (Mar 24) to 0.50, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 1.13. This value is below the healthy minimum of 1.5. It has decreased from 1.23 (Mar 24) to 1.13, marking a decrease of 0.10.
- For Quick Ratio (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. It has decreased from 0.67 (Mar 24) to 0.60, marking a decrease of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.12. This value exceeds the healthy maximum of 8. It has increased from 6.75 (Mar 24) to 9.12, marking an increase of 2.37.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -156.19. This value is below the healthy minimum of 20. It has decreased from -73.02 (Mar 24) to -156.19, marking a decrease of 83.17.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 31.08. This value is within the healthy range. It has decreased from 123.03 (Mar 24) to 31.08, marking a decrease of 91.95.
- For Earning Retention Ratio (%), as of Mar 25, the value is 256.19. This value exceeds the healthy maximum of 70. It has increased from 173.02 (Mar 24) to 256.19, marking an increase of 83.17.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 68.92. This value is within the healthy range. It has increased from -23.03 (Mar 24) to 68.92, marking an increase of 91.95.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.95. This value is within the healthy range. It has increased from 5.07 (Mar 24) to 8.95, marking an increase of 3.88.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.31. This value is below the healthy minimum of 3. It has increased from -1.97 (Mar 24) to 1.31, marking an increase of 3.28.
- For Enterprise Value (Cr.), as of Mar 25, the value is 4,670.05. It has decreased from 5,324.43 (Mar 24) to 4,670.05, marking a decrease of 654.38.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.40 (Mar 24) to 1.15, marking a decrease of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is 10.32. This value is within the healthy range. It has decreased from 23.55 (Mar 24) to 10.32, marking a decrease of 13.23.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has decreased from 1.30 (Mar 24) to 1.04, marking a decrease of 0.26.
- For Retention Ratios (%), as of Mar 25, the value is 256.19. This value exceeds the healthy maximum of 70. It has increased from 173.02 (Mar 24) to 256.19, marking an increase of 83.17.
- For Price / BV (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. It has decreased from 0.81 (Mar 24) to 0.75, marking a decrease of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has decreased from 1.30 (Mar 24) to 1.04, marking a decrease of 0.26.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. It has increased from -0.04 (Mar 24) to -0.01, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gujarat Alkalies & Chemicals Ltd:
- Net Profit Margin: 0.38%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.85% (Industry Average ROCE: 7.11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -1.14% (Industry Average ROE: 8.14%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.31
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.6
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 21 (Industry average Stock P/E: 5)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.09
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.38%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Caustic Soda/Soda Ash | P.O.: Ranoli, Vadodra District Gujarat 391350 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Hasmukh Adhia | Chairman |
| Ms. Avantika Singh Aulakh | Managing Director |
| Mr. Rajiv Lochan Jain | Independent Director |
| Mr. Nitin Shukla | Independent Director |
| Mr. Shridevi Shukla | Independent Director |
| Mr. Bimal Julka | Independent Director |
| Dr. Chinmay Ghoroi | Independent Director |
| Mr. S J Haider | Director |
| Dr. T Natarajan | Director |
FAQ
What is the intrinsic value of Gujarat Alkalies & Chemicals Ltd?
Gujarat Alkalies & Chemicals Ltd's intrinsic value (as of 06 February 2026) is ₹29721.54 which is 6579.00% higher the current market price of ₹445.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,264 Cr. market cap, FY2025-2026 high/low of ₹700/418, reserves of ₹5,497 Cr, and liabilities of ₹8,209 Cr.
What is the Market Cap of Gujarat Alkalies & Chemicals Ltd?
The Market Cap of Gujarat Alkalies & Chemicals Ltd is 3,264 Cr..
What is the current Stock Price of Gujarat Alkalies & Chemicals Ltd as on 06 February 2026?
The current stock price of Gujarat Alkalies & Chemicals Ltd as on 06 February 2026 is ₹445.
What is the High / Low of Gujarat Alkalies & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gujarat Alkalies & Chemicals Ltd stocks is ₹700/418.
What is the Stock P/E of Gujarat Alkalies & Chemicals Ltd?
The Stock P/E of Gujarat Alkalies & Chemicals Ltd is 21,763.
What is the Book Value of Gujarat Alkalies & Chemicals Ltd?
The Book Value of Gujarat Alkalies & Chemicals Ltd is 759.
What is the Dividend Yield of Gujarat Alkalies & Chemicals Ltd?
The Dividend Yield of Gujarat Alkalies & Chemicals Ltd is 3.55 %.
What is the ROCE of Gujarat Alkalies & Chemicals Ltd?
The ROCE of Gujarat Alkalies & Chemicals Ltd is 0.34 %.
What is the ROE of Gujarat Alkalies & Chemicals Ltd?
The ROE of Gujarat Alkalies & Chemicals Ltd is 1.13 %.
What is the Face Value of Gujarat Alkalies & Chemicals Ltd?
The Face Value of Gujarat Alkalies & Chemicals Ltd is 10.0.